UBS AM Portfolio holdings
UBS Asset Management (UBS AM), a division of UBS Group AG with origins tied to the bank’s founding in 1862, is headquartered in Zurich, Switzerland, and manages hundreds of billions in assets for institutional, intermediary, and wealth management clients globally. Specializing in a broad range of investment strategies—including equities, fixed income, multi-asset, alternatives, and sustainable investing—UBS AM leverages the firm’s extensive research capabilities and global network to deliver tailored solutions. Known for its focus on risk management and innovation, it offers products like ETFs, index funds, and private market investments, catering to diverse needs from pension funds to high-net-worth individuals. As part of UBS’s broader ecosystem, UBS AM combines Swiss precision with a commitment to ESG principles, solidifying its position as a leader in the asset management industry.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
AGN
Allergan plc
AGN
|
+$321M |
| 2 |
ESRX
Express Scripts Holding Company
ESRX
|
+$214M |
| 3 |
Zimmer Biomet
ZBH
|
+$207M |
| 4 |
Ecolab
ECL
|
+$192M |
| 5 |
MHFI
MCGRAW-HILL FINANCIAL INC COM
MHFI
|
+$189M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
WBA
Walgreens Boots Alliance
WBA
|
+$251M |
| 2 |
PCP
PRECISION CASTPARTS CORP
PCP
|
+$225M |
| 3 |
AGN
Allergan Inc
AGN
|
+$221M |
| 4 |
Apple
AAPL
|
+$201M |
| 5 |
American Express
AXP
|
+$180M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 16.57% |
| 2 | Technology | 14.63% |
| 3 | Financials | 14.16% |
| 4 | Consumer Discretionary | 9.69% |
| 5 | Industrials | 8.42% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
476
Ingredion
INGR
$6.58B
| $38.6M | 0.04% |
495,811
+319,300
| +181% | +$26.1M |
|
477
Annaly Capital Management
NLY
$17.4B
| $38.5M | 0.04% |
924,778
-23,778
| -3% | -$1.01M |
|
478
Avery Dennison
AVY
$13.4B
| $38.4M | 0.04% |
725,767
+229,779
| +46% | +$12.2M |
|
|
CIE
479
DELISTED
Cobalt International Energy, Inc
CIE
| $38.2M | 0.04% |
270,848
+218,130
| +414% | +$29.4M |
|
480
Bunge Global
BG
$20.8B
| $38.2M | 0.04% |
464,057
+28,035
| +6% | +$2.39M |
|
|
DISH
481
DELISTED
DISH Network Corp.
DISH
| $38.1M | 0.04% |
544,421
-14,416
| -3% | -$1.06M |
|
482
W.R. Berkley
WRB
$26.6B
| $38.1M | 0.04% |
2,547,079
+96,414
| +4% | +$1.43M |
|
483
Synopsys
SNPS
$79.7B
| $38.1M | 0.04% |
822,374
+16,986
| +2% | +$760K |
|
|
ATVI
484
DELISTED
Activision Blizzard
ATVI
| $38M | 0.04% |
1,671,641
-106,960
| -6% | -$2.34M |
|
|
AGU
485
DELISTED
Agrium
AGU
| $37.8M | 0.04% |
362,511
-2,976
| -0.8% | -$318K |
|
486
UDR
UDR
$12.3B
| $37.5M | 0.04% |
1,101,548
-59,395
| -5% | -$1.95M |
|
487
Globe Life
GL
$14.3B
| $37.4M | 0.04% |
680,402
+7,405
| +1% | +$394K |
|
488
Teck Resources
TECK
$32.6B
| $37.2M | 0.04% |
2,708,613
-258,170
| -9% | -$3.64M |
|
489
RenaissanceRe
RNR
$13.4B
| $37.1M | 0.04% |
372,490
+51,642
| +16% | +$5.16M |
|
|
HBI
490
DELISTED
Hanesbrands
HBI
| $36.8M | 0.04% |
1,098,074
+274,842
| +33% | +$8.33M |
|
491
iShares Core S&P 500 ETF
IVV
$902B
| $36.6M | 0.04% |
175,954
+5,595
| +3% | +$1.16M |
|
|
ICPT
492
DELISTED
Intercept Pharmaceuticals, Inc.
ICPT
| $36.2M | 0.03% |
128,525
+6,100
| +5% | +$1.32M |
|
493
Franco-Nevada
FNV
$46B
| $36.2M | 0.03% |
747,038
-575
| -0.1% | -$29.9K |
|
494
Charter Communications
CHTR
$18.2B
| $36.2M | 0.03% |
187,336
-684
| -0.4% | -$119K |
|
495
Lexicon Pharmaceuticals
LXRX
$1.1B
| $36.2M | 0.03% |
5,471,670
+551,850
| +11% | +$3.77M |
|
496
AES
AES
$10.5B
| $36.1M | 0.03% |
2,808,326
+137,441
| +5% | +$1.72M |
|
497
Equifax
EFX
$21.4B
| $36M | 0.03% |
387,625
-10,390
| -3% | -$922K |
|
498
Qorvo
QRVO
$8.74B
| $36M | 0.03% |
+451,878
| New | +$32.2M |
|
|
LLL
499
DELISTED
L3 Technologies, Inc.
LLL
| $35.7M | 0.03% |
283,912
-20,499
| -7% | -$2.61M |
|
500
Textron
TXT
$15.4B
| $35.5M | 0.03% |
800,946
-59,214
| -7% | -$2.58M |
|
Similar funds
UBS AM's Q1 2015 Portfolio in Review
As of Q1 2015, UBS AM held 2,695 positions worth $104B, down 1.3% from $105B the previous quarter. Its ten largest holdings account for 14% of the portfolio.
UBS AM withdrew a net $4.3B in Q1 2015, closing 72 positions and reducing 841 holdings. Its most notable exit was Allergan Inc, an estimated $221M position sold in full.
By sector, the portfolio is most concentrated in Healthcare at 17% of assets, up from 15% a quarter earlier, followed by Technology and Financials.
Against the trend, UBS AM opened a new position in Qorvo worth $36M.
- UBS AM's largest Q1 2015 buy was Qorvo: 451,878 shares worth $36M.
- UBS AM added most to Allergan plc in Q1 2015, an estimated $321M increase.
- UBS AM's biggest Q1 2015 reduction was Walgreens Boots Alliance, cutting an estimated $251M.
- UBS AM fully exited Allergan Inc in Q1 2015, selling an estimated $221M.
- UBS AM's ten largest holdings make up 14% of its $104B portfolio in Q1 2015.
- UBS AM opened 84 new positions and closed 72 in Q1 2015.
- UBS AM's portfolio value fell 1.3% quarter-over-quarter to $104B.
Based on UBS AM's 13F filing for Q1 2015, filed 4 May 2015.